MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Polycythemia Vera (PV) · Essential Thrombocythemia (ET) · Myelofibrosis (MF)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ruttenberg Treatment Center, New York, New York, United States

Study leads

John Mascarenhas
Study Chair
Icahn School of Medicine at Mount Sinai

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Polycythemia Vera · ET (Essential Thrombocythemia) · Polycythemia Vera (PV)

Abroad (travel likely)Recruiting

Chicago, United States · New York, United States

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Polycythemia Vera (PV) · Myelofibrosis (MF) · Myeloproliferative Neoplasms (MPNs)

Abroad (travel likely)RecruitingPHASE1

Denver, United States · Coral Springs, United States

Efficacy and Safety of Peginterferon in ET and PV.

Essential Thrombocythemia · Polycythemia Vera

Abroad (travel likely)Recruiting

Wuhan, China

A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)

Polycythemia Vera (PV)

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Los Angeles, United States